Navigation Links
Top 1000 Pharmaceutical Manufacturers (Asian)
Date:9/29/2011

NEW YORK, Sept. 29, 2011 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

Top 1000 Pharmaceutical Manufacturers (Asian)

http://www.reportlinker.com/p0610984/Top-1000-Pharmaceutical-Manufacturers-Asian.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Pharmaceutical

The Asian Pharmaceutical Manufacturers Industry Report

Plimsoll Publishing Ltd.

This report is an in-depth financial evaluation of the Asian Pharmaceutical Manufacturers Industry. Using the unique Plimsoll method of analysis, each of the top 1000 Asian Pharmaceutical Manufacturers is individually assessed and ranked against each other and compared to industry averages. Using the most up-to-date financial information available, the one-page analysis provides detailed financial and statistical information for each companies, including details of;

• Sales growth

• Trading stability

• Profitability

• Employee performance

• Level of debt

• Gearing ratio's

• Creditor Exposure

• Performance ratio's

• Overall financial rating

Results are shown in graphical, numeric and narrative forms, and all individual analysis are measured in both the company's own currency, and USD ($) for ease of use. These individual analyses highlight a company's success just as easily as it can emphasise its vulnerability.

Along with individual company information, this report also contains an assesment of the market, based on the companies analysed. This key information identifies;

• Best trading partners (based on commercial and financial strength)

• Sales growth (highest sales, growth rate, size of market based on the companies analysed, average growth)

• Profitability (Profit return on assets, pre-tax profit margins, industry average)

• Fastest growing companies (performance matrix)

Companies can change at an alarming rate in a very short space of time, so it is vital that you keep up-to-date with any changes to your market, and how those changes can affect you. This report can provide you with an in-depth look at your industry, highlight new market opportunities and provide important information to help develop accurate strategic business plans. Whether you wish to benchmark your own company's results, study the industry in more depth or have a vast array of industry intelligence at your disposal, this report is the ideal resource.

This extensive report is broken into two parts:

1. A complete financial assessment of the market, based on the companies analysed.

2. An individual financial performance analysis of each company.

Specific areas included in the market assessment include;

Section 1 - Best Trading Partners (based on commercial and financial strength)

1.1a – Best Trading Partners definition and industry top 5 list

1.1b – Performance matrix (Financial Strength Vs Sales Growth)

1.1c – List of Best Trading Partners in the industry

Section 2 - Sales & Market Performance

2.1 – Sales Growth

2.1a – 4 year trend analysis

2.1b – Industry Average Sales Growth

2.1c – Sales Growth Ranking Table

2.1d – Top 50 Companies ranked by Market Share

2.2 – Sales Return on Assets

2.2a – 4 year trend analysis

2.2b – Sales return on total assets

2.2c – Sales return on assets ranking table

2.2d – Top 50 companies' sales return on assets

Section 3 – Profitability

3.1 – Pre-tax profit margin

3.1a – Pre-tax profit margin 4 year trend analysis

3.1b – Industry Average pre-tax profit margin

3.1c – Pre-tax profit margin ranking table

3.1d – Top 50 companies actual pre-tax profit

3.2 - Pre-tax profit return on total assets

3.2a - Pre-tax profit return on total assets 4 year trend analysis

3.2b – Industry average pre-tax profit return on total assets

3.2c – Pre-tax profit return on total assets ranking table

3.3 - Profitability

3.3a – Profitability industry average

4. 0 – How to Use

5.0 – Individual Company Analysis

The individual company assessment gives a complete financial picture of each company listed, including a narrative summary of the analysis. One of our key indicators is the Plimsoll Chart which combines several performance figures to give an overall measurement of the financial strength of any company. The Plimsoll chart is complied through the analysis of several different areas, including;

Sales Growth, Trading Stability, Profitability, Working Capital, Gearing and Immediate Liquidity

As all measurements are standardised, in one report you can quickly compare like with like for every major company in your industry. The accounts of each company appear in its own currency and € to allow comparison.

Each individual company analysis includes:

• A full four year financial assessment, Debtor days analysis, Latest sales/profitability rankings.

• Employee Performance Analysis, Comparisons against industry average.

• Overall company financial rating as read in the Plimsoll Chart, Industry ranking matrix.

• Company analysis written summary.

Other information in the report includes;

• Details of the Plimsoll Model

• Definition of Terms

• List of Shareholders

• Global Index by region

• Ranking Analysis by sales/profits

• Companies considered but not included

• Index of companies

To order this report:

Pharmaceutical Industry: Top 1000 Pharmaceutical Manufacturers (Asian)

Pharmaceutical Business News

More  Industry Analysis and Insights

Nicolas Bombourg
Reportlinker
Email: nbo@reportlinker.com
US: (805)652-2626
Intl: +1 805-652-2626


'/>"/>
SOURCE Reportlinker
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Top 450 Biotechnology (Pharmaceuticals) Report (Global)
2. Experts to Provide Successful Strategies for Global Biopharmaceutical Development and Commercialization at PAREXEL Tokyo Seminar
3. McNEIL-PPC, Inc. Acquires Full Ownership of the Johnson & Johnson-Merck Consumer Pharmaceuticals Co. Joint Venture
4. K-V Pharmaceutical Company to Present at Imperial Capitals 5th Annual Global Opportunities Conference
5. Onyx Pharmaceuticals Submits New Drug Application for Carfilzomib in Relapsed and Refractory Multiple Myeloma
6. Valeant Pharmaceuticals Announces Approval Of Colesevelam Hydrochloride In Canada
7. Ampio Pharmaceuticals Receives Notice of Allowance of its Two Patent Applications on the Combination of Zertane™ with Erectile Dysfunction Drugs in Canada
8. AcelRx Pharmaceuticals Appoints Mark G. Edwards To Its Board of Directors
9. Adamas Pharmaceuticals Initiates a Phase 2/3 Clinical Study of ADS-5102 for Parkinsons Disease
10. Global Protein Purification Reagents Market: An Expanding Role in Biopharmaceutical; Diagnostics; and Basic Biomedical Research
11. Questcor Pharmaceuticals Announces Preliminary Operating Metrics for Third Quarter 2011
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/24/2017)... , Feb. 24, 2017 Research and Markets ... Analysis & Trends - Industry Forecast to 2025" report to ... ... CAGR of around 23.8% over the next decade to reach approximately ... market estimates and forecasts for all the given segments on global ...
(Date:2/24/2017)... Research and Markets has announced the addition of the ... offering. ... Hemophilia Drugs Price Analysis and Strategies - 2016, provides drug pricing data ... following questions: What are the key drugs ... the Global Hemophilia market? What are the unit prices ...
(Date:2/24/2017)... -- In conjunction with DURECT Corporation,s (Nasdaq: DRRX ... are invited to listen to a conference call that ... March 14, 2017 at 4:30 pm Eastern Time (1:30 ... of the presentation will be available by accessing DURECT,s ... If you are unable to participate during the live ...
Breaking Medicine Technology:
(Date:2/24/2017)... (PRWEB) , ... February 24, 2017 , ... ... marketing services, which specializes in thought leadership , media relations, social media, ... and services that will be powered through Act-On, an intuitive marketing automation platform. ...
(Date:2/24/2017)... ... February 24, 2017 , ... ... once again hosted their Military Wedding Giveaway, with the winning couple announced on ... Farms with services generously donated from local vendors: A Matter of Taste, Ryan ...
(Date:2/23/2017)... ... February 23, 2017 , ... ... Justice jointly issued a letter to withdraw previous guidance issued by ... gender identity. The guidance issued in May 2016 by the Obama Administration came ...
(Date:2/23/2017)... ... February 23, 2017 , ... The ... funding innovative lymphoma research and serving the lymphoma community through a comprehensive series ... La Gorce Country Club in Miami Beach to host its Swirl: Miami Wine ...
(Date:2/23/2017)... Chapel Hill, NC (PRWEB) , ... February 23, 2017 , ... ... the Platinum Sponsor for ACPA’s 74th Annual Meeting. KLS is a longtime supporter ... in 2017 as an exhibitor and Platinum Sponsor," said Dr. Bob Havlik, 2017 ACPA ...
Breaking Medicine News(10 mins):